208 related articles for article (PubMed ID: 19304279)
1. High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes.
Krzyzanowska K; Aso Y; Mittermayer F; Inukai T; Brix J; Schernthaner G
Transl Res; 2009 Apr; 153(4):199-203. PubMed ID: 19304279
[TBL] [Abstract][Full Text] [Related]
2. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease.
Inoue T; Kotooka N; Morooka T; Komoda H; Uchida T; Aso Y; Inukai T; Okuno T; Node K
Am J Cardiol; 2007 Aug; 100(4):569-74. PubMed ID: 17697807
[TBL] [Abstract][Full Text] [Related]
3. Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease.
von Eynatten M; Hamann A; Twardella D; Nawroth PP; Brenner H; Rothenbacher D
Eur Heart J; 2008 May; 29(10):1307-15. PubMed ID: 18390868
[TBL] [Abstract][Full Text] [Related]
4. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
[TBL] [Abstract][Full Text] [Related]
5. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.
Schnabel R; Messow CM; Lubos E; Espinola-Klein C; Rupprecht HJ; Bickel C; Sinning C; Tzikas S; Keller T; Genth-Zotz S; Lackner KJ; Münzel TF; Blankenberg S
Eur Heart J; 2008 Mar; 29(5):649-57. PubMed ID: 18263867
[TBL] [Abstract][Full Text] [Related]
6. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.
Seino Y; Hirose H; Saito I; Itoh H
Metabolism; 2007 Nov; 56(11):1493-9. PubMed ID: 17950099
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin.
Aso Y; Yamamoto R; Wakabayashi S; Uchida T; Takayanagi K; Takebayashi K; Okuno T; Inoue T; Node K; Tobe T; Inukai T; Nakano Y
Diabetes; 2006 Jul; 55(7):1954-60. PubMed ID: 16804063
[TBL] [Abstract][Full Text] [Related]
8. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy.
Kato K; Osawa H; Ochi M; Kusunoki Y; Ebisui O; Ohno K; Ohashi J; Shimizu I; Fujii Y; Tanimoto M; Makino H
Clin Endocrinol (Oxf); 2008 Mar; 68(3):442-9. PubMed ID: 17970779
[TBL] [Abstract][Full Text] [Related]
9. Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease.
Hajer GR; van der Graaf Y; Olijhoek JK; Edlinger M; Visseren FL
Am Heart J; 2007 Oct; 154(4):750.e1-7. PubMed ID: 17893004
[TBL] [Abstract][Full Text] [Related]
10. Decreased high-molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of Type 2 diabetes.
Retnakaran R; Connelly PW; Maguire G; Sermer M; Zinman B; Hanley AJ
Diabet Med; 2007 Mar; 24(3):245-52. PubMed ID: 17305786
[TBL] [Abstract][Full Text] [Related]
11. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men.
Seino Y; Hirose H; Saito I; Itoh H
Metabolism; 2009 Mar; 58(3):355-60. PubMed ID: 19217451
[TBL] [Abstract][Full Text] [Related]
12. High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus.
Bobbert P; Rauch U; Stratmann B; Goldin-Lang P; Antoniak S; Bobbert T; Schultheiss HP; Tschoepe D
Diabetes Res Clin Pract; 2008 Nov; 82(2):179-84. PubMed ID: 18778866
[TBL] [Abstract][Full Text] [Related]
13. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis.
Liang KW; Lee WJ; Lee WL; Ting CT; Sheu WH
Clin Chim Acta; 2009 Jul; 405(1-2):114-8. PubMed ID: 19397903
[TBL] [Abstract][Full Text] [Related]
14. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD.
Rizza S; Clementi F; Porzio O; Cardellini M; Savo A; Serino M; Chiricolo G; Romeo F; Lauro R; Federici M
Nutr Metab Cardiovasc Dis; 2009 Jan; 19(1):54-60. PubMed ID: 18472407
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany.
Koenig W; Khuseyinova N; Baumert J; Meisinger C; Löwel H
J Am Coll Cardiol; 2006 Oct; 48(7):1369-77. PubMed ID: 17010797
[TBL] [Abstract][Full Text] [Related]
17. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
[TBL] [Abstract][Full Text] [Related]
18. Effects of losartan on serum total and high-molecular weight adiponectin concentrations in hypertensive patients with metabolic syndrome.
Uchida T; Shimizu M; Sakai Y; Nakano T; Hara K; Takebayashi K; Inoue T; Node K; Inukai T; Takayanagi K; Aso Y
Metabolism; 2008 Sep; 57(9):1278-85. PubMed ID: 18702955
[TBL] [Abstract][Full Text] [Related]
19. Increased total and high-molecular weight adiponectin after extended-release niacin.
Plaisance EP; Grandjean PW; Brunson BL; Judd RL
Metabolism; 2008 Mar; 57(3):404-9. PubMed ID: 18249215
[TBL] [Abstract][Full Text] [Related]
20. Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes.
von Eynatten M; Liu D; Bluemm A; Schuster T; Baumann M; Lutz J; Heemann U; Dugi KA; Nawroth PP; Bierhaus A; Humpert PM
Clin Endocrinol (Oxf); 2009 Jul; 71(1):27-32. PubMed ID: 18778396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
